4/A: Axon Director Amends Stock Sale Details
Amendment to Insider Transaction Report
Axon Enterprise Director Caitlin Kalinowski filed an amended Form 4 to correct details of common stock sales on May 13 and May 14, 2025, previously misreported due to a broker error.
Summary
- An amended Form 4 was filed by Caitlin Elizabeth Kalinowski, a Director of AXON ENTERPRISE, INC. (AXON).
- The amendment corrects a previous Form 4 filed on May 14, 2025, which incorrectly reported a single sale of 800 shares of Common Stock on May 13, 2025.
- The correct information indicates that 657 shares of Common Stock were sold on May 13, 2025, at a price of $713.25 per share.
- An additional 143 shares of Common Stock were sold on May 14, 2025, at a price of $728.53 per share.
- Following these transactions, Kalinowski beneficially owns 6,129 shares of Common Stock directly.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While an error occurred, the prompt correction demonstrates transparency and adherence to regulatory requirements. There's no negative impact on company operations or financial health, only a correction of a director's personal stock transaction.
Positives
- The company and its director are ensuring accurate public disclosure of insider transactions by correcting a previous error.
Negatives
- A broker error led to an initial misreporting of insider stock sales, requiring an amendment.
Risks
- No specific company-wide risks are mentioned. The primary risk addressed is the accuracy of insider trading disclosures, which has now been rectified.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding the company's future performance or operations.
Management Comments
- Due to a broker error, the Form 4 filed for the reporting person on May 14, 2025 incorrectly reported that the reporting person sold 800 shares of Common Stock on May 13, 2025.
- Instead, in accordance with the reporting persons original instructions, 657 shares of Common Stock were sold on May 13, 2025 and an additional 143 shares of Common Stock were sold on May 14, 2025.
- This amended Form 4 provides the correct trade information.
Industry Context
This filing is a routine amendment to an insider trading report and does not provide information relevant to broader industry trends or competitive landscape.
Comparison to Industry Standards
- Not applicable, as this filing pertains to a correction of an individual insider stock transaction rather than company performance or operational results.
Stakeholder Impact
- Shareholders: Provides accurate information regarding insider trading activity, ensuring transparency.
- Regulatory Authorities: Demonstrates compliance with SEC reporting requirements by correcting errors.
Next Steps
- No specific future actions or milestones are mentioned beyond the correction of the historical transaction data.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of first corrected common stock transaction (sale of 657 shares). |
| 05/14/2025 | Date of original Form 4 filing and second corrected common stock transaction (sale of 143 shares). |
| 12/12/2025 | Signature date of the reporting person for this amended Form 4. |
Keywords
AXON, Axon Enterprise, Form 4/A, Insider Trading, Stock Sale, Director, Caitlin Kalinowski, SEC Filing, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.